Updated results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancerShow others and affiliations
2017 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 28, no S5, article id LBA22Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2017. Vol. 28, no S5, article id LBA22
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-346978ISI: 000411324005075OAI: oai:DiVA.org:uu-346978DiVA, id: diva2:1193612
Conference
42nd European-Society-for-Medical-Oncology Congress (ESMO), SEP 08-12, 2017, Madrid, SPAIN
2018-03-272018-03-272018-03-27Bibliographically approved